CorMedix Inc.
CRMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 162.4% | 1.7% | 25.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 89.3% | 95.3% | 95.9% | 96.2% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 55% | 51.6% | 53.3% | 43.6% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 104.1% | 49.9% | 52.8% | 43.1% |
| EPS Diluted | 1.26 | 0.28 | 0.3 | 0.22 |
| % Growth | 350% | -6.7% | 36.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | -$0 |